Dark-field imaging in coronary atherosclerosis

  • Holger Hetterich
  • Nicole Webber
  • Marian Willner
  • Julia Herzen
  • Lorenz Birnbacher
  • Sigrid Auweter
  • Ulrich Schüller
  • Fabian Bamberg
  • Susan Notohamiprodjo
  • Harald Bartsch
  • Johannes Wolf
  • Mathias Marschner
  • Franz Pfeiffer
  • Maximilian Reiser
  • Tobias Saam

Abstract

OBJECTIVES: Dark-field imaging based on small angle X-ray scattering has been shown to be highly sensitive for microcalcifications, e.g. in breast tissue. We hypothesized (i) that high signal areas in dark-field imaging of atherosclerotic plaque are associated with microcalcifications and (ii) that dark-field imaging is more sensitive for microcalcifications than attenuation-based imaging.

METHODS: Fifteen coronary artery specimens were examined at an experimental set-up consisting of X-ray tube (40kV), grating-interferometer and detector. Tomographic dark-field-, attenuation-, and phase-contrast data were simultaneously acquired. Histopathology served as standard of reference. To explore the potential of dark field imaging in a full-body CT system, simulations were carried out with spherical calcifications of different sizes to simulate small and intermediate microcalcifications.

RESULTS: Microcalcifications were present in 10/10 (100%) cross-sections with high dark-field signal and without evidence of calcifications in attenuation- or phase contrast. In positive controls with high signal areas in all three modalities, 10/10 (100%) cross-sections showed macrocalcifications. In negative controls without high signal areas, no calcifications were detected. Simulations showed that the microcalcifications generate substantially higher dark-field than attenuation signal.

CONCLUSIONS: Dark-field imaging is highly sensitive for microcalcifications in coronary atherosclerotic plaque and might provide complementary information in the assessment of plaque instability.

Bibliographical data

Original languageEnglish
ISSN0720-048X
DOIs
Publication statusPublished - 09.2017
PubMed 28941758